April 18, 2025
The clinical trial of the LIVERATION project, funded by Horizon Europe, has reached an important milestone with the recruitment of its 100th patient. The study is already underway in Spain, Italy, Slovenia, and Switzerland, with 8 clinical sites active, and recruitment is ongoing.
This achievement reflects the strong coordination and commitment of a European consortium working to reduce liver cancer recurrence after surgery, through the development and validation of evidence-based strategies.
🌍 A growing European network
The geographical diversity of the trial allows the collection of valuable data across different clinical contexts, strengthening the robustness and applicability of future results. As the remaining associated centres progressively join the active phase of the trial, LIVERATION further establishes itself as a pan-European initiative with real public health impact.
🔭 Looking ahead
Every patient recruited is a step forward — a contribution to scientific knowledge and a chance to improve the outlook and quality of life for those facing liver cancer.
Thanks to all the teams, centres and individuals making this possible.
We continue moving forward with science, commitment and hope.